Market Survey of Different Product of Mankind

A PROJECT REPORT on

MARKET SURVEY OF DIFFERENT PRODUCTS

IN PARTIAL FULFILLMENT FOR THE DEGREE OF

MASTER OF BUSINESS ADMINISTRATION (2009-2011)

SUBMITTED BY

Vipul SatiMBA -3rd Semester.

University Roll: 0928670048

1

VISHVESHWARYA INSTITUTE OFTECHNOLOGY

GHAZIABAD-201001(Affiliated to U.P. TECHNICAL UNIVERSITY,

LUCKNOW.)

Index

2

S.No. CONTENT PageNo.01 Cover Page 0102 Certificate of the Organization 0303 Certificate of the Institute 0404 Declaration 0505 Acknowledgement 0606 Preface 0707 Executive Summary 0808 Company Profile 09-1009 Company History 1110 Mankind Today 1211 1312 Research and Development 1413 Vision and Plan 15-1714 Corporate Social Responsibility 18-1915 Achievements 20-2616 Table of Contents

Introduction 27-30 Objective 31 Research Methodology 32-34 Data analysis & Interpretation 35-47 Finding 48-50 Suggestions & Recommendations 51 Limitations 52 Conclusion 53 Bibliography 54 Annexure 55-56 Chemists 57-77

3

CERTIFICATE

4

This is to certify that Mr.VIPUL SATI has successfully completed his Project

on “Markert Survey of Different Molcules of Cipla in GHAZIABAD, during

the academic year 2009-2011 for partial fulfillment of the course MBA.

DECLARATION

5

I VIPUL SATI student of MBA 3rd semester here by declare that

Market share of different products of Mankind at Ghaziabad, Noida,

Shahiabad, Hapur are correct. I did this suvey very honestly and all the data

that are present in this report are correct upto the best of my knowledge. If

there will be any type of mistake then I will be responsible for that.

VIPUL SATI

MBA 3rd Sem.

University Roll: 0928670048

6

Acknowledgement

My sincere indepthness to all those management people, who cooperated with me

in such a nice way that I did not ever find any of the problem in this short duration

of 60 days, besides, I would also like to converge my regards to Mr.ANIL

KHANDURI (REGIONAL MANAGER) & Mr. MANJUL DIXIT (FIELD

MANAGER) MANKIND for assigning me this project through which I came

across a practical knowledge of present market scenario with great learning

advantage as will.

I would also like to thank the staff members of mankind, all the Chemists for their enriching support and efforts.

This acknowledgement would not be complete without placing on the report

the contribution and support extended by Senior Lecturer Ms.Shuriti Shrivastava

and my friends.We will always cherish to work with the organization, prevailing

such type of culture in it.

7

Last but not the least, with a deep sense of gratitude that I would like to make note of immense encouragement , coaxing and rebuking render by my parents, which has been primarily responsible in coming with this sincere study. I could never thank them enough.

VIPUL SATI

8

Preface

Pharmaceutical market in India has assumed new dimension, because of increased

attention of government to the health needs of its million of inhibitor with the on

set GATT agreement and liberalization.

Pharmaceutical industry is observing various changes in product patents and licensing arrangements. It has increased the flow of technology and investments into this sector, which would play in the long run, esecpially for research and development.

The Pharma industry has garnished us with lost of drugs that have revolutionized in providing better health and relief from ailment to a large section of society.

Mankind has assigned me to work on the project title “Comparative Analysis of different product (Atorvastatin, nemesulide and metoprolol) in Pharmaceutical Industry” in the region Ghaziabad, Noida, Hapur,Shahiabad

9

Executive Summary

In relation to the project titled

“Market study of Atorvastatin, Nemesulide, Metoprolol, with respect to its awareness, availability, prescriptions, brand leader and position in the market in Ghaziabad,noida,hapur,shahiabad.

A sample size of 261 chemists was chosen for these cities. The survey method chosen was shop to shop personal interview to be conducted by me pursuing my MBA., the data collection was extended for over 60 days and Two hundreds Sixty One chemists were interviewed and asked questions regarding their awareness, availability, prescriptions and the sale of Atorvastatin, Nemesulide, Mwtoprolol. I have found the important chemist to whom my company should focus. The data collection originally was on weekly basis and for the purpose of analysis of all the results on monthly basis.

I brought out the fact like the awareness level of the above brand; its availability, current demand and demand potential, market coverage and market potential, sale and main competitors.

10

Company Profile

MANKIND PHARMA PVT.LTD.

Founder: MR.RAJEEV JUNEJA

Founded on: 17th August 1995

11

Established in 1995 with a capital of 50 lakhs, Mankind at present is a

leading pharmaceutical company of India. Our Goal is to help the

community to lead healthy life through two parallel objectives:

formulating, developing & commercializing medicines, and delivering

affordable & accessible medication that satisfy urgent medical needs.

Mankind has out-performed the Indian Pharmaceutical industry by

growing at the rate of 60% year after year. It is among the top 5 fastest

growing Pharma companies of India as per ORG-ims. We have achieved

the turnover of Rs.920 Cr in the fiscal year 2008-09.

Ours is a fully integrated pharmaceutical company having pan India

presence with a comprehensive network of 52 C&F agents & 6000

Stockists. We are ranked 4th in India and 3rd in North India as per

ORG-ims, Prescription Audit, 2008 and as per ORG-ims Prescription /

Doctor / Month audit of Jan.2009, we are ranked 1st in India. Our strong

portfolio of businesses, geographies and products provide us the

strategic benefits of integration that allow us to perform best in an increasingly competitive market.

12

We have a strong market presence in Antibiotics, Antifungals,

Gastrointestinals, NSAIDs, Anthelmintics, Cardiovascular, Dermal and

Erectile Dysfunction categories. Numbers of our products are at top 5

positions as per ORG-ims.

13

Companies & Divisions

Discovery Mankind-Incepted in the year 2003 as a marketing division of Mankind Pharma, today Discovery Mankind is having a wide product range to treat diabetic metabolic disorder. It is also having products in antibiotic, GI , anti fungal & lifestyle segments.

Lifestar Pharma-Launched in the year 2005 as a group company. Lifestar offers comprehensive range of products in ophthalmic & Dermal segment. It is also having product range in antibacterials, GI & other segments.

Special Mankind-Special Mankind launched in Januaray 2007 is poised to meet OTC requirements. This division is pioneer in launching of premium category condoms, toothbrush, sanitary napkins & sweeteners.

14

Future Mankind-Future Mankind was positioned in the year 2007 to cater the growing demand of acute & chronic therapeutic segments. In Future Mankind orthopedic drugs along with GI & other specialty is comprehensively represented in line to Mankind group philosophy.

Magnet Labs-With purpose to cater the growing market of neuropsychological segment Mankind acquired Magnet Labs in the year 2007. It is pioneer in formulations of acute & chronic psychiatric segments.

VetMankind-The strong impact of the philosophy of “Serving Life” lead to the foundation of this division in the year 2007 to serve the Indian animal husbandry needs. It comprises veterinary products in Antibacterials, Nutritionals, Reproductive, NSAIDs , Digestive categories etc.

15

Milestones

2008-

1) Achived 35% growth. 2) 1st rank all over India as per Prescription/Doctor/Month.3) 4th rank in india & 3rd in North India as per ORG-ims & stockist Secondary Audit.4) 21 brands at No. 1 position & 14 brands at No. 2 Position as per ORG-ims & stockist Secondary Audit.5) 53 brands in top 5 position as per ORG-ims & stockist Secondary Audit.

2007-

1) Launched Future Mankind, Special Mankind and VetMankind.2) Acquired Magnet Labs Pvt. Ltd.3) Chrys capital become an investor partner.4) Awarded "Emerging Company of the year" by Indian Express Pharma Pulse.5) Tied up with Roche Diagnostic for the marketing of product ’Accu chek Go’.

16

20061) Established Injectable state-of-the-art unit at Paonta sahib (HP).2) Group Turnover surged upto Rs.512 Cr.

2005-

1) Celebrated “Decade of trust” with medical fraternity. 2) Launched Lifestar Pharma, 3) Awarded by Indian Express Pharma Pulse for “Overall Best Performance” .

2002-

1) Company established its operations all over India.2) Launched new division Discovery Mankind.

1995

- Inception of Mankind Pharma .

17

Company History

THE WORLD OF Mankind

There’ll always be a healthier way to live, a warmer way to care, a surer way to heal, a calmer way to sleep. There’ll always be a better world, for those who have the passion to create it. That’s been Mankind belief since 1995, when we began as a small Indian enterprise committed to the nation’s quest for self-sufficiency. The

Dr. R .C . Juneja Chairman & Dr. A..P.J Kalam

War that followed saw Mankind rise to the challenge of meeting the alarming shortage of essential medicines.

And by the 1990’s Mankind pioneered Bulk Drug manufacturing in the country, which truly laid the foundation for the Pharmaceutical industry in India. Over the years our commitment to heal, protect and enrich lives has only grown, and so have our capabilities.

18

MANKIND TODAY

Today we have 31 world-class manufacturing facilities spread across the country, with dedicated plants for Oncology products, Hormones, Inhalers, Carbapenems, and Cephalosporin’s, among others. They more than meet the stringent international standards, such as that of US FDA, MHRA–UK, TGA , and BFarm

19

RESEARCH AND DEVELOPMENT

R&D is the key to the future of pharmaceutical industry. The pharma advances for considerable improvement in lie expectancy and health all over the would are the result of a steadily increasing investment in research. There is considerablescope for collaborative R&D in India can offer several strengths to the international R&D Commuinity. These relate to availability of excellent scientific telents who can develop combinational chemistry, new synthetic molecules and plant derived candidate drugs.

The R&D expenditure by the Indian pharmaceutical industry is around 1.9% of the industry turnover. This Indian pharmaceutical industry is very low when compared to investment on R&D by foreign research-based pharma companies. They spend 10-16% of the turnover on R&D however, now that India is entering into the patent protction area; many companies are spending relatively more on R&D.

Indian pharmaceutical industry with its rich scientific telent provides cot- effective clinical trial research. It has an excellent record of development of improve, cost-beneficial chemical syntheis for various drug molecules. Some MNC’s are already sourcing these services from their Indian affiliates.

20

The pharmaceutical and Biotechnology industry is eligible for weight deduction for R&D expense up to 150% There R&D companies will also enjoy tax holiday for 10 years. A promotional research and development fund over Rs150corores is set up the government to promote research and development in the pharmaceutical sector.

21

VISON AND PLAN

Intelligent sourcing and acquisition tools based on a deep understanding of industry requirements

Strict data quality; validated and independently assessed

We want the 'SERVING LIFE' to be the industry

STANDARD for licensing.

Helping business development teams by providing a high level of confidence in the documentation and approvals of a potential partner.

Helping developers and manufacturers in matching the requirements of both industry and global business development teams.

"We want the 'Quality Approval Mark' to be the industry STANDARD for licensing."

We want Genericlicensing to be FIRST place to find generic products.

Significantly reduced risk and an improved efficiency of negotiations by giving each company an industry designed profile and ranking system. Attracting product owners by significantly increasing the probability of

22

gaining new clients through access to the largest business development user base in the industry.

Planned developments

Here are some of the features and ideas that we expect to introduce to Genericlicensing during the coming months:

Automatching

As a verified user you will be able to upload your 'wish list' and the database will either return a match or the opportunity to submit an 'interest request'. The additional details can then be used to notify relevant potential developers of your product interest. This can be anonymous if desired.

New Product Surveying

Available to certain level of subscriber and verified users. Based on detailed criteria and certain profile settings, surveys can be sent to the database, requesting users to confirm potential interest in new product ideas. This is designed to help developers and business developments teams quickly understand the possible interest in new product.

Custom Reports

Available to certain level of subscriber and verified users. The opportunity to create bespoke reports based on data obtained from the database. By being able to add user-defined fields, simple integration into current business information systems will help reduce the time and effort required to report on potential opportunities.

User Ratings

In addition to the formal ranking and approval system run by Genericlicensing; users will also be able to add comments and ratings for companies whom they have worked with. This anonymous information will help fellow business development teams to evaluate potential partners.

23

LEARNING

During my training period I get a lot of things under which few things are good and few things are not very good. But during this period I learn that how we can make good relationship with people.

This summer training was very useful for me because, in this period I saw that I was easily able to make good relation with chemists. It is my luck that I have got good experience in the whole training period and I really enjoy my summer training with this company.

24

CULTURE AND VALUE

At Mankind

We believe… Transparency is the key to success

We strive… To make it possible

We are a team… Everyone matters

We achieve…Winning is a habit with us.

We aim high…With our feet firmly on the ground.

We are Mankind…Making dreams reality.

Our employees have always been our tremendous strength, and that is the main reason behind our success. Mankind has always recognized the importance of freedom to express and innovate.

Hence we have cultivated a work culture that permits our employees to learn, innovate & experiment new ideas. Mankind Pharma places a great value on innovation and expects its people to act and think differently.

We continuously encourage all individuals to take up new challenges with adequate responsibilities which has majestically helped us by contributing towards a handsome growth year after year.

25

End Result Focused, which would drive the Performance

Both our customers and products are accorded highest priority with sensitivity, commitment with time & cost for delivering innovative and affordable medicines in local and global market.

Command with Innovation

Everyday we learn something new, make mistakes & again learn from our mistakes. We always allow and tolerate genuine mistakes. We encourage & empower our people to take risks with intelligence .

We know that there is a very thin line between EGO and SELF-RESPECT. Being in the big chair places no guarantee of retaining position and respect. Therefore among our people the status consciousness is minimal; leadership is the buzzword. Credibility & accountability is the essence. Providing access to the people to explore our resources is absolutely unrestricted.

26

CORPORATE SOCIAL RESPOSIBILITY

With businesses focusing on generating profits, sustainability was not a popular concern among companies up until recently. Now, in an era of globalization, multinational corporations (those that conduct business in more than one country) and local businesses are no longer able to conduct destructive and unethical practices, such as polluting the environment, without attracting negative feedback from the general public.

With increased media attention, pressure from non-governmental organizations, and rapid global information sharing, there is a surging demand from civil society, consumers, governments, and others for corporations to conduct sustainable business practices. In addition, in order to attract and retain employees and customers, companies are beginning to realize the...

:

27

Mankind has a strong feeling of Corporate Social Responsibility inscribed in its book of values. Its concern for the society extends well beyond its commercial motives. Mankind feels equally

responsible to return to the society, what it has given of which it is now proud of.

Mankind does not view its success in terms of commercial turnover or profit margin it gains but firmly believes that corporate social responsibility is the key for providing a strong & symbolic

relationship that exists between the company and the society it functions.

28

NANHI KALINanhi kali is a special project jointly managed by

K. C. Mahindra Education Trust and Naandi Foundation, aimed at providing education to the underprivileged girl child in India. The trust has managed 28000 Nanhi Kalis in India, who are

considered a liability and an economic burden to the family. The Trust's efforts are rooted in the

conviction that educating a child is the most effective way of breaking the cycle of poverty.

Mankind with a philosophy of “Serving Life” is not only aiding benefits to the society with its

economical products but also associated with this trust and genuinely heading its responsibility towards the future upbringings of the country.

INSTITUTE FOR THE BLIND ANDH VIDYALAYA Institute for the Blind Andh Vidyalaya is established in the year 1939 at Lahore, is registered under the society act of

1860 having its branch office at Lajpat nagar (South Delhi), is the oldest residential blind institute in Delhi.

This institute has enrolled more than 250 blind students from all over India with an aim to assist the blind population with the general pattern of the society through a process of formal

education and by equipping them with such vocational training to enable them to gain a reasonable degree of economic independence in every aspect. Mankind being committed to society is associated to the social cause for the betterment of these

people in every sphere of life.

29

BMD CAMPSMankind, as a part of its social responsibility is also organizing BMD camps on regular basis throughout India.

The motto behind organizing this camp is to make people aware about the Mineral deficiency in their bones as per their weight and height. Mineral deficiency is common in India which causes osteoporosis in later stage of Life.

SOS Children's villages of India CAMPS

The SOS children's village of india is a non-government, non-profit, voluntary child care organization that was established in 1964 & has since been involved in providing orphaned & distressed children's a 'home-like' environment with a loving mother, brother & sister as well as a home and village. Through 39 Children's villages and 122 allied projects spread across country, SOS provides services to large number of Children in need. Driven by its commitment towards social welfare & highly influned by the SOS concept of providing family support to orphan children, Mankind has been associated with SOS Children's villages of India to help the underprivileged children live a secured life with natural family environment.

30

ACHIVEMENTS

Major Achievements of Mankind:

Manufactured electrokind with zinc for the first time in India

Launch pregnany test slide to check the pregnancy , in association with Indian Institute of Chemical Technology

Launches nosikind drop, the world's first such liquid drop device

Mankind ltd in 2009Introduction:Mankind is one of the most paramount pharmaceutical companies of India. It exports raw materials for making drugs and offers intermediates, prescription drugs, OTC products and veterinary products. It also offers technology for products and processes. With the protocol 'Serving life', Mankind, has achieved many milestones in the medical field and is still on the go of launching new products for health care.

31

In the light of this, Ganesha foresees the future of Mankind in 2009.

Share Holding Pattern:

Corporate Bodies - 1.31

Directors and their Relatives - 39.38

Other including Indian Public - 23.59

Govt. Financial Institutions - 13.82

32

Mankind Tests Indian Patent Law

THE DELHI HIGH COURT last week started hearing Roche's demand for an injunction against the Indian firm am MANKIND, which is marketing a generic version of Tarceva, a Roche lung cancer drug. The case marks the first time that an Indian producer of generic drugs has started local sale of a drug that is under patent protection in that country. Roche received an Indian patent for Tarceva in 2007.

Jean-François Tremblay/C&ENHamied

33

http://www.roche.com/home.html

Mankind, India's leading generic drug company in terms of market share, is selling its own low-cost version of erlotinib, the generic name of Tarceva, under the trade name Erlocip. Cipla sells its copycat drug for about $42 per tablet, versus $125 for the Roche version. The drug needs to be taken once daily.

Alexander Klauser, a spokesman for Roche in Switzerland, says the company is seeking an injunction againsta Mankind largely as a matter of principle. "Just as we respect other people's intellectual properties, we expect ours to be respected," he says. Klauser adds that pharmaceutical patents lie at the root of the system that allows medical innovation to take place. Roche won't provide Tarceva's sales figures in India.

R.C.JUNEJA, Mankind chairman, contends that Roche's patent is invalid in India because the patent application for the drug was originally filed in 1999.

In 2005, India started implementing a new patent regime that grants protection to companies that filed applications for their pharmaceuticals in 1999 or later. This move was in keeping with its obligations as a developing country under the international agreement on Trade-Related Aspects of Intellectual Property Rights

(TRIPS), a World Trade Organization-sanctioned trading treaty.

34

http://www.wto.org/english/tratop_e/trips_e/trips_e.htm

New Drug Discovery

While our skills are among the best in the India, what makes us different is our

multi-disciplinary approach to research. Our research capabilities are extensive, from

Chemical Synthesis, Delivery Systems and Medical Devices to Process Engineering, Animal

Health Products, Neutraceuticals and Biotechnology.We believe there’s no use in

developing life-saving medicines if we can’t make them affordable for the patient.

Today, across India, there are millions of patients who get to use a Mankind

product to prevent, to cure, or for relief from suffering. In their cure and relief lies

the ultimate purpose of what we do.

At Mankind, this has been the driving force behind our continuous Quest for

quality. And quality is an obsession here for the 7000 People who walk into work

every morning.

35

World-class quality is reflected in everything we do – from start to finish. Over the

years, we have taken on the challenges facing the world, tackling the newer dimensions of

diseases, like AIDS. At a time when it was a death sentence and medication was

unaffordable to most, Mankind opened the doors of hope to millions and millions

of patients by becoming the first company in the world to offer the Triple-Drug

AIDS Cocktail for less than a dollar a day. One out of every three HIV-AIDS

patients under treatment in Africa uses a Mankind drug.Mankind, originally

founded as the Chemical, Industrial & Pharmaceutical Laboratories is a

prominent Indian pharmaceutical company,

36

http://en.wikipedia.org/wiki/Pharmaceutical_company

http://en.wikipedia.org/wiki/India

ABOUT MANKIND YEARWISE-

1995

Launched Uttar Pradesh and Madhya Pradesh with 53 Medical Representatives and Manager.Achieved a turnover of 3.8 crores in the first year.

1996 Launched Haryana and Punjab and the field force increased to 90.A turnover of 8.2 crores was achieved with 117% growth.

1997

With a field force of 140 company’s turnover increased to 15 crores with a growth of 77%. Zenflox become NO. 1 brand according to ORG_ims.

1998

Turover was 24 crores with 61% growth and field force grew to 180.

1999

37

Field force increased to 250 with launch of Bihar.Turnover was 31 crores with growth of 31%.

2000

Achieved a milestone of 50 crores with a growth of 60%.Orissa and Maharashtra were launched and field force increased to 308. MANFORCE Ranked NO. 1

2001

Entered Andra Pradesh,turnover reached 67 crores at a growth of 34% and field force increased to 394.

2002

Major achievement of the year was launching of DICOVERY MANKIND.Field force grew to 600 and turnover touched 85 crores with 27% growth.

2003

Achieved a turnover of 150 crores and growth of 77%.Anti_hypertensive brands

were introduced and field force increased to 950.NUROKIND Ranked No.1

2004

Turnover jumped to 250 crores with 67% growth and field force increased to to 1495 in number.Moxikind-CV was successfully launched at a very economical price.

2005

Celeberate a”Decade of Trust” with medical fraternity.Launched a new sister concern LifestarPharma.Group turnover touched Rs.350 crore &field force grew to 1900.Won Indian Express Pharma Pluse Award for overall best performance for the year 2004_2005.

2006

Turnover to Rs.550 crs. With 60%growth &field force increased to 2700 in number.Moxikind_CV & Cefakind become No.1 brands according to ORG_ims.

2007

38

Major achievement of the year starting with starting with the launching of SPECIAL MANKIND/VET MANKIND/FUTURE MANKIND and acquired MAGNET LABS.

2008

Acquired Accuchek Go from ROCHE for marketing in India by DISCOVERY MANKIND.

2009

Turnover jumped to Rs. 920 crs. With 35% of growth.

2010

Turnover jumped to Rs. 1195, purchased LONGIFENE brand from UCB.

AND open his new head office in SRILANKA.

39

Introduction

The Indian pharmaceutical industry is a story which providing employment of million and ensuring that essential drug at affordable price are available to the vast population of this sub-continent.

40

PRESENT SCENARIO

The Indian pharmaceutical industry today is in the rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the Indian pharma industry is estimated to worth $4.5 billion, growing about 8 to 9% annually. It

41

ranks very high in the 3rd world. In terms of technology, quality and range of medicines manufactures from sample headache pills to sophisticated antibiotics, anti-inflammatory, antioxidant, anti-hypertensive, almost every type of medicine in now made indigenously. The Indian pharmaceutical sector is highly fragmented with more than 20000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 8% of the market share. It is an extremely segmented market with severe price competition and govt. price control. The pharmaceutical industry in India meets around 70% of the country’s demand for bulk drug, drug intermediates, and pharmaceutical formulation. Chemical tablets, capsules, orals and ingestible. There are about 250 large units and about 8000 scale units, which from the core of the pharmaceutical industry in India (including 5 central public sector unit). These units produce the complete range of pharmaceutical formulation i.e. medicine ready for consumption by patient and about 350 bulk drugs i.e. chemical therapeutic value and used for production of pharmaceutical formulation.

42

Advantage in India

The foreign player because of various reasons choosing India.

1. Competent Workforce : India has a pool of personal with high managerial and technical competence as also skilled workforce. It has an educated work force and English is commonly used. Profession services are easily available.

2. Cost-effective Chemical Synthesis : It track record of development, particularly in the are of improved cost-beneficial chemical synthesis for various drug molecules is excellent. It provides a wide variety of bulk drugs and exports sophisticated bulk drugs.

3. Legal and Financial framework : Indian has a 53 year old democracy and hence has a solid legal framework and strong financial market. There is already an established international industry and business community.

4. Information technology : It has a good network of world class educational institution and established strengths in information technology.

5. Globalization : The country is committed to a free market economy and globalization. Above all its has a 75 million middle class market which its continually growing.

6. Consolidation : For the first time in many year, the international Pharmaceutical industry is finding great opportunities in India. The Process of consolidation, which has become a generalized phenomenon in the world pharmaceutical industry, has started taking place in India.

43

Growth Scenario

India US $ 3.1 billion pharmaceutical industry is growing at the rate of 16% per year. It is one of the largest and must advance among the developing countries.Over 20,000 registered Pharmaceutical Manufactures exit in the country. The domestic Pharmaceutical industry output is expected to exceed Rs. 260 billion in the financial year 2010. Which accounts for nerely 1.3% of the global Pharmaceutical sector? Of this, bulk drugs will account for Rs. 5 bn (21%) and formulations, the remaining Rs. 210 bn (79%). In financial year 2004 imports were Rs. 56 billion while exports were Rs. 120 bn.

44

Steps to strengthen the Industry

Indian companies need to attain the right product mix for sustained future growth-core competencies with play an important role on determining the future of many Indian Pharmaceutical Companies, in an effort to consolidate their positions will have to increasingly look at merger and acquisition of new product options, improve their R&D effort improve distribution to penetrate markets.Research and development has always taken the back seat amongst Indian pharmaceutical companies. In order to stay competitive in the future, Indian companies will have to refocus and invest heavily in R&D.

The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, if forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisition, co marketing and licensing agreements.

The Indian pharmaceutical industry is highly regulated. The government control prices of a large number of bulk and formulation. Profit margins of player very widely in both domestic and export sales due to many factors.

DOMESTIC TRADE

More than 85% of the formulations produced in the country are sold in the domestic market, India’ largely self sufficient in case of the formulation. Some life saving, new generation under-patent formulation continues to be imported, especially by Marks, which then market them in India. Overall, the size of domestic formulations market is around Rs160bn and it is growing at 11% per annum.

45

EXPORTS:-

Over 60% of the India bulk production is exported. The balance is sold locally to

other formulations. India’s Pharmaceutical exports are to tune of Rs87bn of which

formulations contribute nearly 55% and the rest 45% comes from bulk drugs. In

financial year 2000 exports grew by 21% India’s Pharmaceutical imports were to

tune of Rs20.3bn in FY 2001. Imports have registered a AGR of only 2% in the

past 5 year. Import of bulk drug has slowed down in the recent year. The export of

pharmaceuticals during the year 1998-97 were Rs49780 million. From a merger

Rs46 crores worth of pharmaceuticals and fine chemicals during april-october

(2000-2001) was 4.1%an increase of 7%.

46

Research Objective

My research objective is comparative analysis of different brand in

PHARMACUETICAL INDUSTRY of different molecules.The molecule are –

Atorvastatin

Matoprolol

Nemesulide

1. To find out the whether the chemist are aware about these salt or not ?

2. To find out which brand of particular salt is being prescribed by doctors

most and why?

3. To find out competitors of these molecules?

47

Research Methodology

One-structured questionnaires were prepared which consisted of open as well as close-ended questions with regard to information that was sought for carrying the project. The questionnaire was prepared for one types of target population viz:Chemists/retailers.

Research DesignNature of Research:-

Since source of secondary data directly relevant were scares. It was decided that the analysis had to be primary data analysis, collected directly from the chemists/retailers. The survey method was chosen to be a shop-to-shop PERSONAL INTERVIEW survey.

Due to availability of knowledge of specific problems, the research could be classified as a descriptive research (conclusive). It was aimed to access the market potential and to get an idea about the awareness & availability of Atorvastatin, Matoprolol, and Nemesulide.

Sampling technique stratified sampling & area sampling

Sample elements: 261 chemist’s retailers

Sample extent: Ghaziabad,noida,shahiabad,hapur.

Type of Data: Primary Data: Because data was collected directly from the

market, No previous data were available.

Sample time: 7 th june to 7th August.

48

Questionnaire Design

A questionnaire is undoubtedly one of the most crucia determinants of a research’s effectiveness. It was collection of open and closed ended question.

The questionnaire is attached as annexure.

Sampling process:

Target all the major chemists Focus on Availability of these molecules-Atorvastatin, Matoprolol, and

Nemesulide.

Plan of data analysis :

The study was meant to be a descriptive and graphical representation is used to visualize the scenario builds up by the research.

49

Field Work

The data collection is through the response of questionnaire and personal interviewing. Even through personal interviewing is time consuming process as compared to other methods available. The chance of getting more accurate results is more than that of other methods. The questionnaire constituted closed – ended questions. The data collection was over a period of 60 days. The delay was due to the fact that data collection was on shop-to-shop personal interview basis.

Data collection efforts were carried out from:-

9: 00 A.M. to 5: P.M.

Precautions:-

Following of right respondent

Following the right sequencing of questioning

50

Data Analysis

And

Interpretation

51

0

5

10

15

20

25

30

Medicines

M ar ke t S h ar e( % )

Series1

Series1 14.08 13.41 13.53 13.02 8.96 9.67 27.33

LipikindAtorva Tonact Storwash

T.G.Tor

Atorlipd

Others

Market Share of Different Brand of Atorvastatin in Ghaziabad

In Ghaziabad LIPIKIND cover maximum share of market so it is a leading brand.LIPIKIND is a product of MANKIND.Atorlip is the economical brand.

52

0

10

20

30

40

50

60

Medinices

m ar ke t s h ar e ( %

)

Series1

Series1 55 6 24 3 4 8

Amlokind-AT

Met-X Star Pres-XL

Meto-ER

Met Pur-XL

Meta Loc

Market Share of Different Brand of Matoprolol in GHAZIABAD.

In Ghaziabad Amlokind_AT cover maximum share of market so it is a leading brand. Amlokind_AT is a product of MANKIND.

53

0

5

10

15

20

25

30

35

Medicines

M ar ke t S h ar e(

%

)

Series1

Series1 27.96 29.59 5.55 12.64 5.92 14.79 3.55

Nobel-MD

Telma Nicip Pyrestat

Nimodol

Pyrimidede

Teliact

Market Share of Different Brand of Nemesulide in Ghaziabad.

In Ghaziabad TELMA a leading brand. Telma is a product of Glenmark.nobel_MD is the second highest brand of the market.It is the product of MANKIND.

Market Share of Different Brand of Atorvastatin in Noida.

54

0

5

10

15

20

25

Medicines

M ar ke t S h ar e Series1

Series1 22 20 19 9 13 17

Lipikind

Tonact Atorfit Storwash

Atorlip Others

\

In Noida Lipikind cover maximum share of market so it is a leading brand.Lipikind is a product of Mankind.

Market Share of Different Brand of Matoprolol in Noida

55

05

1015

2025

3035

4045

Medinices


)Series1

Series1 20.06 6.03 42.68 6.05 5.93 19.25

Metolar-XR

Met-XAmlokind-AT

Meto-ER

Met Pur-XL

Meta Loc

In Noida Amlokind_AT cover maximum share of market so it is a leading brand.Amlokind_AT is a product of Mankind. Metolar-XR is the second highest brand of the market.It is the product of Cipla.

Market Share of Different Brand of Nemesulide in Noida

56

0

10

20

30

40

50

60

70

Medicines

M ar ke t S h ar e(

%

)

Series1

Series1 5.1 3.11 11.61 57.22 5.67 3.13 14.16

Cresar Telma Telista Nobel-MD

Telday Telsartan

Others

In Noida Nobel_MD cover maximum share of market so it is a leading brand. Nobel_MD is a product of Mankind. The position of Cipla product is not good.

Market Share of Different Brand of Atorvastatin in Shahiabad

57

0

5

10

15

20

25

Medicines

M ar ke t S h ar e ( %

)

Series1

Series1 12.25 13.4 6.47 16.69 13.79 15.4 22

Lipikind Atorva Atorlip Tonact Storwash

T.G.Tor

Others

In Shahiabad Tonact cover maximum share of market so it is a leading brand.Lipikind position is not very bad in this area but they should improve it.

Market Share of Different Brand of Matoprolol in Shahiabad

58

0

5

10

15

20

25

30

35

Medinices


)

Series1

Series1 32 11 26 6 12 13

AmloKind-AT

Met-X Star Pres-XL

Meto-ER

Met Pur-XL

Meta Loc

In Shahiabad Amlokind_AT cover maximum share of market so it is a leading brand. Amlokind_AT is a product of MANKIND

Market Share of Different Brand of Nemesulide in Shahiabad

59

0

5

10

15

20

25

Medicines

M ar ke t S h ar e(

%

)

Series1

Series1 12.8 18.82 17.11 21.96 5.93 10.38 13

Nobel_MD Telma TelistaTazlocTeldayTelsart

anOthers

In Shahiabad Tazloc a leading brand. Tazloc is a product of USV.Nobel_MD position is not good in this area.It is the product of Mankind.

Market Share of Different Brand of Atorvastatin in Hapur

60

0

5

10

15

20

25

Medicines

M ar ke t S h ar e ( %

)

Series1

Series1 12.81 14.28 21.18 16.75 10.66 7.96 16.36

Lipikind Atorva Atorlip Tonact Storwash

T.G.Tor

Others

In Hapur Atorlip is a leading brand. Atorlip is a product of Cipla.It is the cheap product in compressin to other. Lipikind position is not good in this area

Market Share of Different Brand of Matoprolol in Hapur

61

0

5

10

15

20

25

30

35

Medinices


)

Series1

Series1 29 11 26 9 11 13

Amlokind-AT Met-X Star

Pres-XLMeto-

ERMet Pur-

XLMeta Loc

In Hapur Amlokind_AT cover maximum share of market so it is a leading brand. Amlokind_AT is a product of Mankind.

Market Share of Different Brand of Nemesulide in Hapur

62

0

5

10

15

20

25

30

Medicines

M ar ke t s h ar e(

%

)

Series1

Series1 17.81 21.92 19.18 2.74 3.74 8.59 26.02

Nobel-MD

Nicip Pyrestat

Nimodol

Pyrimide

Telsartan Others

In Hapur NOBEL_MD is not a leading brand.Nobel_MD is a product

ok Mankind.

Findings

Ghaziabad

63

Market Share of Atorvastatin:-

Lipikind = 14.08%, Atorva = 13.41%, Tonact =13.53%, Storwash = 13.02%, ,

T.G.Tor = 08.96% ,Atorlip =09.67%, Others =27.33 %.

Lipikind Covers maximum market share comparison to above brands in

Ghaziabad.

Market Share of Matoprolol:-

Amlokind_AT = 55.52%, Met-XL=4.48%, Starpress =23.59%, , Metpur-XL =4 %,

Metaloc =07.69%.

Amlokind_AT covers maximum market share comparison to above brand in

Ghaziabad.

Market share of Nemesulide:-

Nobel_MD =27.96%, Telma =29.59%, NICIP =05.55%, Pyrestat =12.64%,

Nimodol =05.92%, Pyrimide =14.79%, Teliact =03.55%.

Telma covers maximum market share comparison to above brand in Ghaziabad.

NOIDA

Market Share of Atorvastatin:

64

LIPIKIND = 21.96%, Tonact = 20.09%, Atorfit =18.69%, Storwash = 08.57%, ,

Atorlip =13.40%, Others =17.29 %.

Lipikind Covers maximum market share comparison to above brands in NOIDA.


Metolar-XR = 20.06%, Met-XL=06.03%, Amlokind_AT =42.68%, Meto- ER =

06.05%, Metpur-XL =05.93 %, Metaloc =19.25%.

Amlokind_AT covers maximum market share comparison to above brand in Noida.


Cresar =05.10%, Telma =03.11%, Telista =11.61%, Nobel_MD =57.22%, Telday

=05.67%, Telsartan =03.13%, Other =14.16%.

Nobel_MD covers maximum market share comparison to above brand in Noida.

Shahiabad


Lipikind = 12.25%, Atorva = 13.40%, Tonact =16.69%, Storwash = 13.79%,

T.G.Tor = 15.40% , Atorlip=6.45% , Other =22.25%

Tonact Covers maximum market share comparison to above brands in Shahiabad.


Amlokind_AT = 32.33%, Met-XL=10.76%, Starpress-XL =25.86%, Meto- ER =

06.47 %, Metpur-XL =11.98 %, Metaloc =12.60%.

Amlokind_AT covers maximum market share comparison to above brand in

Shahiabad.


65

Amlokind_AT =12.8% ,Telma =18.82% ,Telista =17.11% ,Tazloc

=21.96% ,Telday =5.93% ,Telsar =10.38% , Other=13%

Tazloc covers maximum market share comparison to above brand in Shahiabad

Hapur


Lipikind = 12.81%, Atorva = 14.81%, Tonact =16.75%, Storwash = 10.66%,

T.G.Tor = 07.96% , Atorlip =21.18%, Others =16.36 %.

Atorlip Covers maximum market share comparison to above brands in Hapur.


Amlokind_AT = 29.34%, Met-XL=11.48%, Starpress-XL =25.95%, Meto- ER =

09.21%, Metpur-XL =10.91 %, Metaloc =13.11%.

Amlokind_AT covers maximum market share comparison to above brand in Hapur.


Nobel_MD =17.81%, Nicip =21.92%, Pyrest =19.18%, Nimodol =02.74%,

Pyrimide =03.74%, Telsartan =08.59%, Other =26.02%.

Nobel_MD covers maximum market share comparison to above brand in Hapur.

.

Suggesitions and Recommendations

66

From the data representations and interpretation, I conclude and recommend that:

In order to increase the market share in Ghaziabad, Noida, and Hapur&Shahihabad of its Lipikind, Amlokind_AT, and Nobej_MD should try to make more calls at regular intervals to CHEMIST because chemists play an important role in final selling of the product there.

To capture more market share Mnakind should focus on general physicians too.

Good and formal relationship with prescribers/Doctors.

Slight compromise with the pricing of these drugs should be made and it should be made down somewhere to the leading brands.

Frequent technological department is necessary as it obsletes very soon as the more advance one comes.

Value chain should be improved-provides competitive edge.

Company should try for leaving its old traditional generics research.

Distribution network should be maintained all over in Ghaziabad, Noida, Hapur&Shahihabad.

Replacement schemes must be offered in case the drugs get expired at chemist’s shop.

67

LIMITATIONS OF THE STUDY

No name and address of the doctors on the prescription leaflet. The chemist shop – especially those that were around the hospitals and medicine institutional, did not tell prescribers name.

Non-cooperative behavior of the chemists.

Demands may vary as per the need.

All the things are based on the response given by the respodent so any false information given by respondent could make the actual result wrong.

Some people didn’t have enough time to fill up the questionnaire.

68

Conclusion :

It is really a knowledgefull project for me. In this project I come to know how to convince the people. After working over the project I come to know that Mankind is market leader in many molecules in ghaziabad and it is also in a strong position in Noida in this category but they should pay their attention in other molecule like Amlokind_AT, Nobel_MD because in these molecules position is not so good. There are many competitor in the market and they have good share on many molecule.These companies are Ranbaxy, Lupin.Mankind is under the category of top Indian companies facing tough competition with it’s competitors.There were some limitations on my work area inspite of these I completed this project with the right guidance of my mentor and support of retailers in Ghaziabad, Noida, Hapur & Shahiabad.

69

Bibliography

Books

R. Panneersevam Research MethodologyC.R. Kothari Research MethodologyPhilip kotler Principal of Marketing

Websitewww.mankindpharma.comwww.indiainfoline.comwww.ibef.org

News PapersBusiness LineEconomic TimesThe Hindu

MagazinesBusiness TodayBusiness LineMankind magazines

70

Annexure

Questionnaire

Name of the medical store:-

Chemist’s Name:-

Address:-

Ph. No. :-

Q1. Do you have Atorvastatin salt in your shop?

(a) Yes (b) No

(a) Rfed, brand (b) Comp. Name (c) Quality Sold (d) Doctor’s Name

1 1 1 1

2 2 2 2

3 3 3 3

4 4 4 4

5 5 5 5

71

Q2. Do you have Matoprolol in your shop?

(a) Yes (b) No


1 1 1 1

2 2 2 2

3 3 3 3

4 4 4 4

5 5 5 5

72

Q3. Do you have Nemesulide in your shop?

(a) Yes (b) No


1 1 1 1

2 2 2 2

3 3 3 3

4 4 4 4

5 5 5 5

Thanking You

Signature Date

Stamp

73

CHEMISTS

Chemist_id Chemist ShopNameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id NameChemist Shop Adderess Of ShopPhone N0-Chemist_ idChemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-

1Harsh medical storeGandhi Nagar Ghaziabad097220115952Meheta medical storeGandhi Nagar Ghaziabad098370807193Lalit Medical HallNehru Nagar 3rd Ghaziabad098376380254Shiva medicak storeDelhi Gate Ghaziabad059123184495Goyal Medical StoreHapur road Ghaziabad092196952866Prince Medical StoreDelhi Gate Ghaziabad059123184497Jain Medical StoreHapur Road Ghaziabad059124279418A.M. Medical Point Hapur Road Ghaziabad094128657359Vineet Medical StorHapur Road Ghaziabad0941224550710Bhagat MedicoseHapur Road Ghaziabad-

74

Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop Name

11Sharma Medical StoreNehru Nagar 3rd Ghaziabad0983792182312Shri Sayi MedicoseDelhi Gate Ghaziabad0971958755113Shivam Medical StoreHapur Road Ghaziabad-14Vabhave Medical StoreHapur Road Ghaziabad0935823558715Veer Medical StoreHapur Road Ghaziabad-16Akash Medical StoreArjun Nagar Ghaziabad0901255612317Shri Laxmi Medical StoreArjun Nagar Ghaziabad-18New Yes Medicose Arjun Nagar Ghaziabad936816682219Ajay Medical StoreArjun Nagar Ghaziabad0983723247620Depali Medical StoreShastri Nagar Ghaziabad0591653308821Gujrati Medical HallShastri Nagar Ghaziabad0591242838222Abhishek Medical StoreShastri Nagar Ghaziabad0591440775

75

Adderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-

76

Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop Name

77


78

Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop Name

79


80

Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No-Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop Name

81

Adderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No-

82

Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop Name

83


84


85

Adderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of Shop Phone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No-

86


87


88


89


90


91


92

Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist Name

93

Chemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id

94

Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- hemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No-

95

Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of Shop

96

Phone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No- Chemist_id Chemist NameChemist Shop NameAdderess Of ShopPhone No-

97

Market Survey of Different Product of Mankind

Documents

Transcript of Market Survey of Different Product of Mankind